Loading...
The current standard of care and the unmet needs for axial spondyloarthritis
The aim of this article is to explore the benefits and limitations of the established treatments for axial SpA (axSpA), including physiotherapy, NSAIDs, conventional synthetic DMARDs and biologic DMARDs such as TNF inhibitors (TNFis). It also briefly discusses the emerging role of anti-IL-17 therapy...
Na minha lista:
| Udgivet i: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6238225/ https://ncbi.nlm.nih.gov/pubmed/30445485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/key217 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|